A “double mutant” strain of the CCP virus believed to be behind a spike of cases in India has been discovered in California’s Bay Area, officials confirmed Sunday. The first case of the variant, which is feared to be more infectious, was identified and confirmed by the Stanford Clinical Virology Lab through genetic sequencing, Stanford Health Care spokesperson Lisa Kim told the San Francisco Chronicle. Stanford is also screening seven further presumptive cases of the “double mutant” strain, which carries two mutations in the spike protein—L452R and E484—that may help the virus bind more readily to receptors in human cells. It is unclear whether the emerging strain is more resistant to the three COVID-19 vaccines that have been authorized for emergency use in the United States so far—Pfizer/BioNTech, Moderna, and Johnson & Johnson. “This Indian variant contains two mutations in the same virus for the first time, previously seen on separate …